Search Press releases Keywords From To 20 Oct 2021 UCB to license its AI technology that improves identification of Osteoporosis to ImageBiopsy Lab Read More 18 Oct 2021 Disposals of own shares Read More 16 Oct 2021 Update on U.S. FDA Review of Biologics License Application (BLA) for bimekizumab Read More 8 Oct 2021 Disposals of own shares Read More 29 Sep 2021 New BIMZELX[®]▼ (bimekizumab) two-year data in moderate to severe plaque psoriasis presented at the 30th European Academy of Dermatology and Venereology (EADV) Congress Read More 24 Sep 2021 Disposals of own shares Read More Pagination First page Previous page Previous … Page 36 Page 37 Page 38 Page 39 Current page 40 Page 41 Page 42 Page 43 Page 44 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
